Chief Financial Officer

Vice President and Chief Compliance Officer, Region US

Glenmark Pharmaceuticals Inc., USA to launch Ropivacaine Hydrochloride Injection USP, 40 mg/20 mL (2mg/mL), 150 mg/30 mL (5 mg/mL), and 200 mg/20 mL (10 mg/mL) Single-Dose Vials

Glenmark Pharma to launch Ropivacaine Hydrochloride Injection USP in US

New Drug Approvals and their Contract Manufacture, 2025 Edition: How Global Issues Affect Pharma Manufacturers

Global General Anesthesia Drugs Market To Reach $6.08 Billion By 2029 With A Growth Rate Of 3.9%

0.4285714328289032

Director, Payer National Accounts

Fresenius Kabi USA is seeking a Director, Payer National Accounts responsible for developing and executing strategic operating plans for key national accounts. The role involves managing customer relationships, securing access for products, and directing internal teams to optimize product revenue and customer engagement.

CEO & Co-Founder

co-founder and chief Scientific Officer

FDA Outlines Principles for Using MRD to Garner Accelerated Approval of Multiple Myeloma Therapies

Adaptive Biotechnologies' Preliminary Full-Year 2025 Revenue Rises 55 Percent

Planet Labs PBC, Day One Biopharmaceuticals, Rxsight, SunOpta And Other Big Stocks Moving Higher On Monday

Adaptive Biotechnologies sees Q4 revenue $72M, consensus $59.38M

Senior Director, National Payer Accounts

Adaptive Biotechnologies is a company focused on transforming disease diagnosis and treatment through the adaptive immune system. They are seeking a Senior Director, National Payer Accounts to develop and execute strategies for expanding patient access to their diagnostic tests by building relationships with national and regional payers and influencing payer decision-making.

Chief Human Resources Officer

President

JPM26: Revolution Medicines in spotlight as industry gears up for dealmaking spree

Dow Jones Top Company Headlines at 9 PM ET: Trump 'Inclined' to Keep Exxon Out of Venezuela | Allegiant ...

Dow Jones Top Company Headlines at 11 PM ET: Trump 'Inclined' to Keep Exxon Out of Venezuela | Allegiant ...

Dow Jones Top Company Headlines at 1 AM ET: Trump 'Inclined' to Keep Exxon Out of Venezuela | Allegiant ...

0.7142857313156128

National Account Director, Payer

Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies. The National Account Director will establish and maintain strategic relationships with national payers to secure optimal market access for oncology medicines, leading engagement and developing account plans to support patient access.

National Account Director, Payer (United/Optum/Emisar)

National Account Director, Payer (united Optum Emisar)

National Account Director, Payer (united Optum Emisar) in united states (1000+)

Director, Payer National Accounts

Senior Director, National Payer Accounts

National Account Director, Payer (United/Optum/Emisar)